Oramed Pharmaceuticals Inc. - Common Stock — Quarterly Financial Data (NASDAQ:ORMP) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Dividends per share ———0.25— — Dividend yield % ———8.77— — Payout ratio % ———100— —

News

Oramed: Oral Insulin Drug Failure Pivot, New Strategic Investment Direction (ORMP)

Scilex Holding files lawsuit alleging securities fraud in California court

Oramed stock rises after receiving $18 million payment from Scilex

Oramed receives $18 million payment from Scilex, declares dividend

Oramed Pharmaceuticals director Leonard Sank to resign after 18 years

Oramed Pharmaceuticals completes $28.5 million warrant repurchase by Scilex

Scilex Holding Co sells shares worth $12.7 million

Oramed Pharmaceuticals: Scarred, Well-Capitalized, And Regrouping After Setback

Oramed Pharmaceuticals repurchases shares and ends joint venture with HTIT

Oramed to launch new oral insulin trial after terminating joint venture

Oramed Pharmaceuticals stockholders approve incentive plan amendment, re-elect directors